Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Cambrex Corporation    CBM

Delayed Quote. Delayed  - 06/27 10:01:44 pm
48.64 USD   -0.41%
06/06 CAMBREX : to Present at the Jefferies 2016 Global Healthcare Confere..
06/03 Cambrex to Present at the Jefferies 2016 Global Healthcare Confer..
05/23 Cambrex Announces Closing of New $500 Million Senior Credit Facil..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
06/21/2016 06/22/2016 06/23/2016 06/24/2016 06/27/2016 Date
47.94(c) 48.17(c) 49.51(c) 48.84(c) 48.64(c) Last
336 748 229 239 249 042 526 052 553 221 Volume
-2.44% +0.48% +2.78% -1.35% -0.41% Change
More quotes
Financials ($)
Sales 2016 475 M
EBIT 2016 119 M
Net income 2016 80,7 M
Debt 2016 -
Yield 2016 -
Sales 2017 525 M
EBIT 2017 136 M
Net income 2017 92,0 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 19,89
P/E ratio 2017 17,53
Capi. / Sales2016 3,29x
Capi. / Sales2017 2,98x
Capitalization 1 562 M
More Financials
Company
Cambrex Corp. engages in the provisio ofproducts, services and technologies to accelerate and improve the development and commercialization of new and generic therapeutics.It supplies its products and services to innovator and generic pharmaceutical companies.Its products include generic and... 
Sector
Pharmaceuticals
Calendar
07/28Earnings Release
More about the company
Surperformance© ratings of Cambrex Corporation
Trading Rating : Investor Rating :
More Ratings
Latest news on CAMBREX CORPORATION
06/06 CAMBREX : to Present at the Jefferies 2016 Global Healthcare Conference
06/03 Cambrex to Present at the Jefferies 2016 Global Healthcare Conference
05/23 Cambrex Announces Closing of New $500 Million Senior Credit Facility
05/16 Cambrex to Present at UBS Global Healthcare Conference
05/03 CAMBREX : Reports First Quarter 2016 Financial Results; Sales increased 20% and ..
04/30 CAMBREX : posts 1Q profit
04/29 CAMBREX CORP : Results of Operations and Financial Condition, Financial Statemen..
04/29 Cambrex Reports First Quarter 2016 Financial Results
04/29 CAMBREX : Reports First Quarter 2016 Financial Results
04/27 Cambrex to Present at the Deutsche Bank 41st Annual Health Care Conference
More news
Sector news : Pharmaceuticals - NEC
06/27DJMayne Pharma Buys US Drugs from Teva, Allergan for $652 Million
06/27 ELI LILLY : Large Outflow of Money Witnessed in Eli Lilly and Company
06/27 RELIABLE STOCKS IN TODAYS SHARE MARK : BioMarin Pharmaceutical Inc.
06/27 MOST IMPORTANT STOCKS OF THE DAY : BioMarin Pharmaceutical Inc.
06/27 EISAI : and UCL Reach First Scientific Milestone in Neurodegenerative Disease Dr..
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
05/28 LANNETT : Structural Benefits Of The Kremers Acquisition: 100+% Upside
04/30 Cambrex's (CBM) CEO Steven Klosk on Q1 2016 Results - Earnings Call Transcrip..
04/29 Cambrex revenues up 20%; earnings up 76%; Non-GAAP EPS up 72% in Q1, updates ..
04/29 Cambrex beats by $0.16, beats on revenue
04/28 Notable earnings before Friday?s open
Advertisement
Chart CAMBREX CORPORATION
Duration : Period :
Cambrex Corporation Technical Analysis Chart | CBM | US1320111073 | 4-Traders
Full-screen chart
Technical analysis trends CAMBREX CORPORATION
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions